Leukocyte-Poor Platelet-Rich Plasma For Arthroscopic Rotator Cuff Repair .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Leukocyte-Poor Platelet-Rich Plasma as an Adjuvant to Arthroscopic Rotator Cuff Repair Reduces the Retear Rate But Does Not Improve Functional Outcomes: A Double-Blind Randomized Controlled Trial.
Am J Sports Med . 2024 May;52(6):1403-1410.Ninety-six patients with rotator cuff tears smaller than 3 cm were randomized to receive either arthroscopic rotator cuff repair (ARCR) with leukocyte-poor platelet-rich plasma (LP-PRP) injection (n=48) or ARCR without PRP (n=48). The primary outcome was the retear rate, assessed via MRI at six months. Secondary outcomes included pain (VAS), functional scores (ASES, SANE), and sleep quality (PSQI), evaluated at six and twelve months postoperatively. Overall, the study found that the retear rate in the PRP group was significantly lower than in the control group (15.2% vs. 34.1%, p = 0.037). However, there were no significant differences in functional outcomes between groups. The findings suggest that while LP-PRP reduces the retear rate, it does not provide clinically significant improvements in pain or function.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics